Tumor Ablation Market Size To Reach $4.0 Billion By 2030

Tumor Ablation Market Growth & Trends

The global tumor ablation market size is anticipated to reach USD 4.0 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 13.5% from 2024 to 2030. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

 Request a free sample copy or view report summary: Tumor Ablation Market Report

Tumor Ablation Market Report Highlights

• Radiofrequency ablation technology segment led the market with a share of more than 32.7% in 2023 owing to prominent application in solid tumor removal

• Microwave ablation segment is expected to grow at the fastest CAGR of 14.27% from 2024 to 2030

• The percutaneous ablation treatment segment held the largest revenue share of about 56.7% in 2023

• Tumor ablation in lung cancer treatment is anticipated to witness the fastest growth from 2024 to 2030. Sedentary lifestyle, increasing incidences of smoking, and rising air pollution are contributing to the growing prevalence of lung cancer

• North America led the global market in 2023 owing to increased prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

Tumor Ablation Market Segmentation

Grand View Research has segmented the global tumor ablation market based on technology, treatment, application, and region:

Tumor Ablation Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Radiofrequency Ablation

• Microwave Ablation

• Cryoablation

• Irreversible Electroporation

• HIFU

• Other Ablation Technologies

Tumor Ablation Treatment Outlook (Revenue, USD Million, 2018 - 2030)

• Surgical Ablation

• Laparoscopic Ablation

• Percutaneous Ablation

Tumor Ablation Application Outlook (Revenue, USD Million, 2018 - 2030)

• Kidney Cancer

• Liver Cancer

• Breast Cancer

• Lung Cancer

• Prostate Cancer

• Other Cancers

Tumor Ablation Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait